Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression

Wang, S; Zhou, LY; Ji, N; Sun, CT; Sun, LL; Sun, J; Du, YW; Zhang, NN; Li, YG; Liu, WS; Lu, W

Zhang, NN; Lu, W (通讯作者)，Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Liver Canc Ctr, Dept Hepatobiliary Oncol,Natl Clin Res Ctr Canc,Ke, Tianjin 300060, Peoples R China.;Li, YG; Liu, WS (通讯作者)，Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Clin Lab, Tianjin, Peoples R China.

DRUG RESISTANCE UPDATES, 2023; 69 ():

Abstract

Acylphosphatase 1 (ACYP1), a protein located in the mammalian cell cytoplasm, has been shown to be associated with tumor initiation and progression by......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索